Tulip Jhaveri is an Infectious Disease physician affiliated with University of Mississippi Medical Center. OpenAlex indexes 32 publications with 501 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
- Astellas Pharma US IncProgram year20241 payment
- PfizerProgram year20231 paymentResearch
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Azole Antifungal51.6%Fluconazole100%Part D<11 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor48.4%Entecavir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of universal decolonization in intensive care units on rates of hospital-acquired Staphylococcus aureus infections
American Journal of Infection Control
2026 - P-2039. Impact of Universal Decolonization in Intensive Care Units on Rates of Hospital-Acquired Staphylococcus aureus Infections
Open Forum Infectious Diseases
2026 - ADLM Guidance Document on Laboratory Diagnosis of Respiratory Viruses
The Journal of Applied Laboratory Medicine
2024 - A decade of clinical microbiology: top 10 advances in 10 years: what every infection preventionist and antimicrobial steward should know
Antimicrobial Stewardship & Healthcare Epidemiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gailen Marshall, MD
University of Mississippi Medical Center
Brian Borg, MD
University of Mississippi Medical Center
Nils Mungan, MD
University of Mississippi Medical Center
Celso Gomez-Sanchez, MD
University of Mississippi Medical Center
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Henry Masur, MD
National Institutes of Health
Vance Fowler, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”